We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.895
Bid: 0.87
Ask: 0.92
Change: 0.00 (0.00%)
Spread: 0.05 (5.747%)
Open: 0.895
High: 0.895
Low: 0.895
Prev. Close: 0.895
JPEL Live PriceLast checked at -
JPEL Private Equity is an Investment Trust

To effect an orderly realisation of the investments and other assets comprised in the portfolio of the company and will seek to realise such investments and assets in order to maximise returns to US equity shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tender Offer

24 Feb 2012 08:37

RNS Number : 0608Y
J.P. Morgan Private Equity Ltd
24 February 2012
 



 

J.P. MORGAN PRIVATE EQUITY LIMITEDCOMPLETES TENDER OFFER TO PURCHASE SHARES

* * *

 

GUERNSEY, 24 FEBRUARY 2012

 

J.P. Morgan Private Equity Limited (the "Company") is pleased to announce that it has accepted the following shares tendered to it at the applicable Net Asset Value per share as at 31 December 2011:

·; 10,706,290 of US$ Equity Shares at a price of USD 1.27 per share1.

o As discussed in the Company's Circular dated 17 November 2011, the total US$ Equity Shares available for tender was 10,706,336 or 3.0% of the 356,877,850 US$ Equity Shares in issue (excluding treasury) at the time that the tender authority was granted.

The 10,706,336 US$ Equity Shares available for tender represents 2.6658772% of the 401,606,496 US$ Equity Shares in issue (excluding treasury) as of the date of the Circular (17 November 2011).

The scaling ratio for US$ Equity shares tendered in excess of the basic entitlement was 0.0033898.

 

·; 153,284 of 2013 Zero Dividend Preference shares at a price of GBP 0.6570 per share.

 

·; 1,514,935 of 2015 Zero Dividend Preference shares at a price of GBP 0.6267 per share.

 

The number of US$ Equity Shares accepted differs from those which were available for tender due to rounding in order to accommodate each shareholder's basic entitlement.

 

The date of the purchase was 21 February 2012. Cheques were despatched / CREST accounts were credited on 24 February 2012 in respect of the shares tendered. All payments were made in the respective base currencies of each share class.

The shares tendered are held as treasury shares. As a result of this tender offer, the Company holds 25,802,704 US$ Equity Shares, 2,259,803 2013 Zero Dividend Preference Shares and 2,344,176 2015 Zero Dividend preference shares in treasury.

 

Immediately following the tender offer the Company's issued share capital will consist of 386,890,704 shares of no par value (excluding treasury shares) each classified as US$ Equity Shares, 63,159,021 shares of no par value (excluding treasury shares) each classified as 2013 Zero Dividend Preference shares, 67,077,371 shares of no par value (excluding treasury shares) each classified as 2015 Zero Dividend Preference Shares, 30,410,753 shares of no par value (excluding treasury shares) each classified as 2017 Zero Dividend Preference Shares.

Therefore the total number of voting rights in the Company is 386,890,704 for the US$ Equity Share class, 63,159,021 for the 2013 Zero Dividend Preference share class and 67,077,371 for the 2015 Zero Dividend Preference share class. These figures may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FSA's Disclosure and Transparency rules.

 

* * *

 

For further information please contact:

 

J.P. Morgan Private Equity Limited

Troy Duncan / Greg Getschow

+44 (0)20 7742 3032 / +1 212 648 1150

Troy.duncan@jpmorgan.com / Gregory.getschow@jpmorgan.com

 

 

Rosemary DeRise / Samantha Ladd

+1 212 648 2980 / +1 212 648 2982

Rosemary.DeRise@jpmorgan.com / Samantha.Ladd@jpmorgan.com

 

 

* * *

 

About J.P. Morgan Private Equity Limited

 

J.P. Morgan Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL, JPWW, JPEZ, JPZZ, JPSZ) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market.

 

 

END

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TENEAPALADSAEEF
Date   Source Headline
23rd Apr 20245:18 pmRNSDirector Declaration
15th Mar 20246:15 pmRNSNet Asset Value - December 2023
15th Mar 20246:03 pmRNSHalf-year Report - December 2023
15th Mar 20243:50 pmRNSHalf-year Report - 2023
6th Dec 20235:36 pmRNSDirector Declaration
6th Dec 20235:33 pmRNSAGM RESULTS 2023
9th Nov 202311:56 amRNS2023 AGM CIRCULAR
8th Nov 20237:00 amRNSCompletion of Twelfth Mandatory Redemption
24th Oct 20237:00 amRNSTwelfth Mandatory Redemption & Shareholder Update
20th Oct 202310:28 amRNSNet Asset Value - September 2023
21st Sep 20235:33 pmRNSNet Asset Value(s) - June 2023
21st Jun 20233:36 pmRNSDirectorate Change
12th May 20231:46 pmRNSNet Asset Value(s) - March 2023
28th Mar 20233:32 pmRNSHalf-year Report - 31 December 2022
14th Mar 20234:35 pmRNSPrice Monitoring Extension
14th Mar 20232:05 pmRNSSecond Price Monitoring Extn
14th Mar 20232:00 pmRNSPrice Monitoring Extension
14th Mar 202311:05 amRNSSecond Price Monitoring Extn
14th Mar 202311:00 amRNSPrice Monitoring Extension
14th Mar 20239:05 amRNSSecond Price Monitoring Extn
14th Mar 20239:00 amRNSPrice Monitoring Extension
24th Feb 20234:22 pmRNSNet Asset Value(s) - December 2022
13th Feb 20234:51 pmRNSDirector Declaration
22nd Dec 20227:00 amRNSCompletion of Eleventh Mandatory Redemption
14th Dec 20227:00 amRNSELEVENTH MANDATORY REDEMPTION & SHAREHOLDER UPDATE
13th Dec 20225:09 pmRNSDirectorate Change
29th Nov 20224:33 pmRNSAGM Results 2022
9th Nov 20224:11 pmRNS2022 AGM CIRCULAR
27th Oct 20226:26 pmRNSNet Asset Value - September 2022
23rd Sep 20224:54 pmRNSAnnual Financial Report - 30 June 2022
13th Sep 20223:03 pmRNSNet Asset Value(s) - June 2022
13th Jul 202211:36 amRNSNet Asset Value(s) - May 2022
6th Jul 20224:26 pmRNSHolding(s) in Company
6th Jul 20227:00 amRNSUpdate to Shareholders
23rd Jun 20225:10 pmRNSNet Asset Value(s) - April 2022
17th May 20227:00 amRNSNet Asset Value(s) - March 2022
11th May 202211:27 amRNSNet Asset Value - February 2022
6th May 20227:00 amRNSNet Asset Value - January 2022
5th May 20225:39 pmRNSHolding(s) in Company
3rd May 20227:00 amRNSPortfolio Update
11th Apr 202212:34 pmRNSCompletion of Tenth Mandatory Redemption
4th Apr 20227:00 amRNSTenth Mandatory Redemption
17th Mar 20225:35 pmRNSHalf-year Report - 31 December 2021
7th Mar 20229:44 amRNSNet Asset Value - December 2021
19th Jan 20221:47 pmRNSNet Asset Value - November 2021
22nd Dec 20214:24 pmRNSNet Asset Value - October 2021
23rd Nov 20212:13 pmRNSAGM Results 2021
16th Nov 20214:42 pmRNSNet Asset Value - September 2021
3rd Nov 202112:29 pmRNSNet Asset Value - August 2021
2nd Nov 20211:49 pmRNS2021 AGM CIRCULAR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.